The global fundus cameras market size is expected to reach USD 535.0 million by 2030, registering a CAGR of 6.2% from 2023 to 2030. The rising geriatric population and growing occurrences of chronic disorders such as diabetes and hypertension further increase the incidence of retinal disorders.
For instance, according to the WHO 2016 report, globally, in 2014, 422.0 million people had diabetes. Additionally, increasing non-communicable diseases such as AMD, diabetic retinopathy, and glaucoma is contributing to the growing blind population globally. Therefore, to control the impact of these eye diseases, the fundus camera is widely used for diagnosis purposes. Availability of different types of fundus cameras such as hybrid, portable, handheld, and standalone is expected to propel the market growth during the forecast period.
Diabetic Retinopathy (DR), Retinopathy of Prematurity (ROP), and Age-Related Macular Degeneration (AMD) are major and increasing causes of retinal blindness. An increase in life expectancy has led to a rise in the geriatric population, which would further continue to rise in the future. According to the U.S. Census Bureau, international database, the global geriatric population was nearly 617.1 million in 2015 and is anticipated to reach 998.7 by 2030. This, in turn, is expected to drive the overall market growth during the forecast period.
In addition, supportive government regulations for fundus cameras are expected to fuel the market growth during the forecast period. For instance, regulatory agencies in the U.S. and Japan stated that the cameras should be replaced every 4 years. This initiative by the agencies will help in implementing new advancements in fundus photography every 4 years, thereby, enhancing the diagnosis of eye diseases. However, the presence of other advanced technologies such as OCT for the diagnosis of eye problems is expected to hinder the adoption of fundus cameras and may impact the overall market growth during the forecast period.
For instance, according to the WHO 2016 report, globally, in 2014, 422.0 million people had diabetes. Additionally, increasing non-communicable diseases such as AMD, diabetic retinopathy, and glaucoma is contributing to the growing blind population globally. Therefore, to control the impact of these eye diseases, the fundus camera is widely used for diagnosis purposes. Availability of different types of fundus cameras such as hybrid, portable, handheld, and standalone is expected to propel the market growth during the forecast period.
Diabetic Retinopathy (DR), Retinopathy of Prematurity (ROP), and Age-Related Macular Degeneration (AMD) are major and increasing causes of retinal blindness. An increase in life expectancy has led to a rise in the geriatric population, which would further continue to rise in the future. According to the U.S. Census Bureau, international database, the global geriatric population was nearly 617.1 million in 2015 and is anticipated to reach 998.7 by 2030. This, in turn, is expected to drive the overall market growth during the forecast period.
In addition, supportive government regulations for fundus cameras are expected to fuel the market growth during the forecast period. For instance, regulatory agencies in the U.S. and Japan stated that the cameras should be replaced every 4 years. This initiative by the agencies will help in implementing new advancements in fundus photography every 4 years, thereby, enhancing the diagnosis of eye diseases. However, the presence of other advanced technologies such as OCT for the diagnosis of eye problems is expected to hinder the adoption of fundus cameras and may impact the overall market growth during the forecast period.
Fundus Cameras Market Report Highlights
- The non-mydriatic cameras segment dominated the market and accounted for the largest market share of 49.5% in 2022 due to increased demand, as it enables the practitioner to view the retinal anatomy in detail and provides enhanced diagnosis and management of eye diseases
- Non-mydriatic and mydriatic camera can be further sub-segmented into tabletop and handheld. The tabletop segment dominated the market in 2022 because of the availability of a higher number of commercialized products and the ability to produce a better image quality than handheld products
- The mydriatic fundus cameras segment accounted for around 20.0% share in 2022. The low share of the mydriatic camera or traditional fundus camera is attributed to the necessity of pupil dilation with the help of bright light or dilating drop to obtain a clear image of the retina.
- North America dominated the fundus cameras market and accounted for the largest revenue share of 37.4% in 2022.Major factors contributing to the growth of this region include the increasing geriatric population and technical advances in the field.
- Asia-Pacific is expected to grow at the fastest CAGR of 6.4% during the forecast period because of the local presence of key players, the availability of expert services, and growing medical tourism.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Fundus Cameras Market Variables, Trends & Scope
Chapter 4. Fundus Cameras: Product Estimates & Trend Analysis
Chapter 5. Fundus Cameras: End Use Estimates & Trend Analysis
Chapter 6. Fundus Cameras Market: Regional Estimates & Trend Analysis
Chapter 7. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- Carl Zeiss Meditec Inc.
- Kowa Company Ltd.
- Optomed Oy (Ltd)
- Optovue, Incorporated
- CenterVue SpA
- NIDEK Co., Ltd
- Topcon Medical Systems Inc.
- Clarity Medical Systems, Inc.
- Canon Inc.
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 140 |
Published | December 2023 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 332.7 Million |
Forecasted Market Value ( USD | $ 535 Million |
Compound Annual Growth Rate | 6.2% |
Regions Covered | Global |
No. of Companies Mentioned | 9 |